Bioprocess Control Specialist Focuses on Single-Use Sensors
Lab Automation through Single-Use Sensors and Monitors
Lonza Upgrades Live-Cell Imaging System
For Obtaining Better Cell-Culture Analyses
Antibody Characterization Balances Rigor and Reason
Emphasizes a Combination of Antibody-Dependent and -Independent Testing Methods
Cancer Immunotherapy Spurs Work on Better Animal Models
GEN Spoke to Several Researchers on Advances in Engineered Animal Models Used to Study Novel Cancer Im-munotherapies
Search Results for
Forum Explores Cognitive Frontier
April 15, 2014
We are a purpose-built company," says Deborah Dunsire, M.D., Forum's new president and CEO. Prior to joining Forum, Dr. Dunsire was president and CEO of Millennium: The Takeda ...
Mersana, Takeda Team Up to Develop ADCs
April 7, 2014
More » April 7, 2014 Mersana, Takeda Team Up to Develop ADCs Mersana Therapeutics inked an agreement with Millennium Pharmaceuticals, a wholly-owned subsidiary of Takeda ...
NIH Coaxes Big Biopharma to AMP Up Drug Development
February 4, 2014
biopharmas include AbbVie, Biogen Idec, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson unit Janssen Research and Development, Merck & Co., Sanofi, and Takeda. ...
Sanford-Burnham Wins $275M Commitment toward Strategic Vision...
January 28, 2014
The institute said it will refine drug candidates through preclinical validation to facilitate stronger partnerships with pharmas, such as those it maintains with Takeda ...
GEN's List of Top Pharma and Biotech Firms
January 15, 2014
(Bayer, Eli Lilly, Novartis, Pfizer, and Sanofi); and the remaining five ranked the same as last year (Astellas, Daiichi Sankyo, Glaxo-SmithKline, Johnson & Johnson, and Takeda). ...